Steven Cohen’s NEVRO CORP. NVRO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-4,500
| Closed | -$25.2K | – | 2554 |
|
|
2024
Q3 | $25.2K | Sell |
4,500
-148,000
| -97% | -$1.04M | ﹤0.01% | 1922 |
|
|
2024
Q2 | $1.28M | Buy |
152,500
+148,200
| +3,447% | +$1.58M | ﹤0.01% | 1207 |
|
|
2024
Q1 | $62.1K | Buy |
+4,300
| New | +$71.1K | ﹤0.01% | 2046 |
|
|
2023
Q4 | – | Sell |
-277,296
| Closed | -$5.33M | – | 2963 |
|
|
2023
Q3 | $5.33M | Buy |
277,296
+277,277
| +1,459,353% | +$5.91M | 0.02% | 860 |
|
|
2023
Q2 | $471 | Buy |
+19
| New | +$549 | ﹤0.01% | 2026 |
|
|
2023
Q1 | – | Sell |
-240,790
| Closed | -$9.54M | – | 2593 |
|
|
2022
Q4 | $9.54M | Buy |
+240,790
| New | +$10M | 0.03% | 563 |
|
|
2020
Q4 | – | Sell |
-147,441
| Closed | -$20.5M | – | 1179 |
|
|
2020
Q3 | $20.5M | Buy |
+147,441
| New | +$19.7M | 0.11% | 266 |
|
|
2020
Q1 | – | Sell |
-39,282
| Closed | -$4.62M | – | 1139 |
|
|
2019
Q4 | $4.62M | Sell |
39,282
-182,672
| -82% | -$18.1M | 0.02% | 512 |
|
|
2019
Q3 | $19.1M | Buy |
221,954
+73,578
| +50% | +$5.57M | 0.12% | 230 |
|
|
2019
Q2 | $9.62M | Sell |
148,376
-87,583
| -37% | -$5.45M | 0.05% | 389 |
|
|
2019
Q1 | $14.8M | Sell |
235,959
-1,082,748
| -82% | -$50.9M | 0.07% | 317 |
|
|
2018
Q4 | $51.3M | Sell |
1,318,707
-171,935
| -12% | -$7.64M | 0.25% | 111 |
|
|
2018
Q3 | $85M | Buy |
1,490,642
+1,405,680
| +1,654% | +$87.9M | 0.35% | 71 |
|
|
2018
Q2 | $6.78M | Sell |
84,962
-357,820
| -81% | -$29.7M | 0.03% | 534 |
|
|
2018
Q1 | $38.4M | Sell |
442,782
-376,879
| -46% | -$30.4M | 0.16% | 170 |
|
|
2017
Q4 | $56.6M | Buy |
819,661
+276,709
| +51% | +$22.1M | 0.24% | 110 |
|
|
2017
Q3 | $49.3M | Buy |
542,952
+141,963
| +35% | +$12.2M | 0.22% | 119 |
|
|
2017
Q2 | $29.8M | Buy |
400,989
+96,989
| +32% | +$7.77M | 0.17% | 161 |
|
|
2017
Q1 | $28.5M | Buy |
304,000
+83,800
| +38% | +$7.59M | 0.16% | 175 |
|
|
2016
Q4 | $16M | Buy |
220,200
+207,100
| +1,581% | +$17.7M | 0.11% | 226 |
|
|
2016
Q3 | $1.37M | Sell |
13,100
-256,400
| -95% | -$23.2M | 0.01% | 602 |
|
|
2016
Q2 | $19.9M | Sell |
269,500
-192,600
| -42% | -$13.1M | 0.14% | 184 |
|
|
2016
Q1 | $26M | Buy |
462,100
+334,900
| +263% | +$19.8M | 0.2% | 141 |
|
|
2015
Q4 | $8.59M | Sell |
127,200
-266,500
| -68% | -$14.3M | 0.07% | 319 |
|
|
2015
Q3 | $18.3M | Buy |
393,700
+79,584
| +25% | +$3.86M | 0.14% | 203 |
|
|
2015
Q2 | $16.9M | Buy |
+314,116
| New | +$16M | 0.12% | 225 |
|
Other funds holding NVRO
ACH
AC
B
RSCM
SC
Steven Cohen's NVRO Position: Q4 2024 in Review
Steven Cohen sold out of NEVRO CORP. (NVRO) in Q4 2024, closing a stake of 4,500 shares — an estimated $25.2K sold.
Steven Cohen first reported a position in NVRO in Q2 2015 and held it in 26 quarters. The position peaked at $85M in Q3 2018. 129 funds tracked by Wall St. Rank hold NVRO as of Q4 2024.
- Steven Cohen reported no remaining NEVRO CORP. position as of Q4 2024 after selling out during the quarter.
- Steven Cohen sold 4,500 NEVRO CORP. shares in Q4 2024, an estimated $25.2K.
- Steven Cohen first reported a position in NEVRO CORP. in Q2 2015 and held it in 26 quarters.
- Steven Cohen's NEVRO CORP. position peaked at $85M in Q3 2018.
- 129 funds tracked by Wall St. Rank held NEVRO CORP. as of Q4 2024.
Based on Point72 Asset Management's 13F filing for Q4 2024, filed 14 Feb 2025.